MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/jcma.0000000000000194

Медицинская библиотека · Journal of the Chinese Medical Association : JCMA · 2020

A high-dose rapamycin treatment alleviates hepatopulmonary syndrome in cirrhotic rats.

Chang Ching-Chih, Chuang Chiao-Lin, Hsin I-Fang, Hsu Shao-Jung, Huang Hui-Chun, Lee Fa-Yauh, Lee Shou-Dong

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Rapamycin is a type of immunosuppressive agent that acts through inhibition of mammalian target of rapamycin (mTOR). Hepatopulmonary syndrome (HPS) is a lethal complication in cirrhotic patients. It is characterized by hypoxia and increased intrapulmonary shunts, in which pulmonary inflammation and angiogenesis play important roles. The current study aimed to evaluate the effect of rapamycin on HPS using the experimental model of common bile duct ligation (CBDL)-induced cirrhosis in rats.

METHODS

The rats received low-dose (0.5 mg/kg), high-dose (2 mg/kg) rapamycin, or vehicle from the 15th to the 28th day post CBDL. Then the mortality rate, hemodynamics, biochemistry parameters, arterial blood gas and plasma levels of vascular endothelial growth factor (VEGF) and tumor necrosis factor (TNF)-α were evaluated on the 28th day post CBDL. Pulmonary histopathological stains were performed, and protein expression was examined. In parallel groups, the intrapulmonary shunts of CBDL rats were measured.

RESULTS

Compared with the control, a high-dose rapamycin treatment decreased portal pressure and improved hypoxia in CBDL rats. It also reduced the plasma level of VEGF and TNF-α and decreased intrapulmonary shunts. Meanwhile, it ameliorated pulmonary inflammation and angiogenesis and downregulated the protein expression of mTOR, P70S6K, nuclear factor kappa B (NFκB), VEGF, and VEGF receptor 2. In contrast, low-dose rapamycin did not attenuate intrapulmonary shunts despite ameliorating portal hypertension.

CONCLUSION

High-dose rapamycin ameliorates HPS in cirrhotic rats as evidenced by the alleviated hypoxia and decreased intrapulmonary shunts. Downregulation of the mTOR/P70S6K, NFκB, and VEGF signaling pathways might play a key role.

Для цитирования: Chang Ching-Chih, Chuang Chiao-Lin, Hsin I-Fang, Hsu Shao-Jung, Huang Hui-Chun, Lee Fa-Yauh, Lee Shou-Dong. A high-dose rapamycin treatment alleviates hepatopulmonary syndrome in cirrhotic rats.. Journal of the Chinese Medical Association : JCMA. 2020. DOI: 10.1097/jcma.0000000000000194.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.